e-learning
resources
Berlin 2001
Monday 24.09.2001
Lung cancer: surveys and prognosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Survival of patients resected for lung cancer in the period 1986 - 1977. Sensitivity of staging, prognostic factors, impact of adjuvant chemotherapy and radiotherapy
K. Silhankova, M. Pesek, V. Spidlen, P. Mukensnabl (Plzen, Czech Republic)
Source:
Annual Congress 2001 - Lung cancer: surveys and prognosis
Session:
Lung cancer: surveys and prognosis
Session type:
Thematic Poster Session
Number:
1588
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Silhankova, M. Pesek, V. Spidlen, P. Mukensnabl (Plzen, Czech Republic). Survival of patients resected for lung cancer in the period 1986 - 1977. Sensitivity of staging, prognostic factors, impact of adjuvant chemotherapy and radiotherapy. Eur Respir J 2001; 16: Suppl. 31, 1588
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Long time survival after resection for multiple primary lung cancers. A population-based study
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005
Impact of neoadjuvant therapies on surgical indications and early postoperative outcome
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005
Treatment of potentially resectable locoregional (stage III) non-small cell lung cancer
Source: Annual Congress 2005 - PG2 - Lung cancer: non-small cell lung cancer treatment
Year: 2005
Improved overall survival after early recurrence of lung cancer following the introduction of CT-based follow-up for patients initially treated with curative intent by (chemo)radiotherapy (CRT).
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Source: Eur Respir J 2009; 34: 17-41
Year: 2009
Neo-adjuvant chemotherapy: level of evidence in early stage and in marginally resectable disease
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005
Comparative evaluation of resectability, postoperative morbidity and mediastinal downstaging after cisplatin-based chemoinduction versus radiochemoinduction for stage III non-small cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 214s
Year: 2003
Current surgical treatment of nonsmall cell lung cancer 2001
Source: Eur Respir J 2002; 19: 61S-70S
Year: 2002
What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
The 7-year results of the surgical treatment of non-small cell lung cancer (NSCLC) patients and the influence of neoadjuvant treatment
Source: Annual Congress 2007 - Therapy of thoracic malignancies
Year: 2007
Impact of radiotherapy on survival rates in chemotherapy treated small cell lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Long-term follow-up comparing postoperative chemotherapy or radiotherapy and surgery with surgery alone in resectable nonsmall cell lung cancer (NSCLC)
Source: Eur Respir J 2001; 18: Suppl. 33, 131s
Year: 2001
Is there any place for perioperative radiation therapy?
Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts
Year: 2005
Radiotherapy and chemotherapy for elderly patients with stage I–II unresected lung cancer},
Source: Eur Respir J 2012; 40: 957-964
Year: 2012
Impact of radiotherapy on survival rates in chemotherapy treated non small cell lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Impact of neoadjuvant therapy on tumor resectability and survival of patients with locally advanced non-small cell lung cancer
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011
Survival after induction chemotherapy and surgery in N2 (mediastinoscopy) NSCLC patients
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009
Adjuvant chemotherapy uptake and survival of patients with NSCLC after complete resection: Single institution/single area experience.
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Respective indications of chemotherapy, radiotherapy and surgery in limited disease stage small cell lung carcinoma
Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Year: 2005
Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept